Funding Received
$13.9 Million in 2 Rounds from 4 Investors
Most Recent Funding
$4.7 Million Series B on November 2, 2012
Founded:
2002
Headquarters:
Montréal, QC
Description:
Alethia BioTherapeutics is a biotechnology company developing monoclonal antibody-based therapeutics for cancer-associated diseases.
Categories:
Biotechnology
Website:
http://www.alethiabio.com

Detailed Description

Update

Alethia BioTherapeutics, Inc., a biotechnology company, engages in the discovery and development of monoclonal antibody-based therapeutics focusing on the cancer-associated epithelial-to-mesenchymal transition, ovarian cancer, and on cancer-induced bone loss. Its products include Isogranulatimide, a G2 checkpoint inhibitor, which potentiates the response to several DNA-damaging chemotherapeutic agents; sCLU, a heterodimeric disulphide-linked glycoprotein of 449 amino acids, the over-expression of which is observed in various malignancies, including prostate, bladder, kidney, breast, colon, and lung tumors; AB-0447, an antigen that is expressed at the surface of ovarian cancer epithelial cells in greater than eighty five percent of malignant tumors; and AB-0440, a cell-surface protease-like protein, whose expression is stimulated early in osteoclast differentiation in response to RANK ligand. The company was founded in 2002 and is based in Montreal, Canada.

Current Team (9)

Update

Board Members and Advisors (3)

Update

Investors (3)

Update
  • Ad3bc7fc72681dcf0e3979842de6b091

    AgeChem Venture Fund

    The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in...
  • Bf2333d0da2fdd635613e46f9ebcad9b

    BDC Venture Capital

    BDC Venture Capital is a major venture capital investor in Canada, active at every stage of the...
  • 945d22676c8902bbb07cf5c9a34dc3a0

    GO Capital Fund

    GO Capital is a $50 million venture capital fund intended to support young Quebec technology...

Offices/Locations (1)

Update
  • Office

    141, Président-Kennedy ave.

    Suite SB-5100, Quebec,

    Montréal, QC H2X 1Y4

    CAN